Industry / Romania
Currency Fluctuations Hurt Farmexim Finances
May 2008 | Industry NewsRomanian drug distributor Farmexim has posted losses of EUR5.5mn (US$8.55mn) for 2007, in the wake of depreciation of the new lei. The company finished 2007 with a turnover of RON496mn (US$211mn), up by 35% year-on-year (y-o-y), and income of RON5.8mn (US$2.47mn). However, foreign currency debts and the Ministry of Health's refusal to adjust drug prices to the new lei exchange rates have hit the company
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
